Back

Serum light-chain neurofilament, a brain lesion marker, correlates with CHA2DS2-VASc score among patients with atrial fibrillation: a cross-sectional study

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Atrial fibrillation - Stroke prevention Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Stefanie Aeschbacher

University Hospital Basel, Basel (Switzerland)

10 More presentations in this session

Presentation thumbnail
Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: a dose subgroup analysis of the ARISTOPHANES study
Doctor X. Li (Princeton, US)
Abstract Slides
Presentation thumbnail
Age threshold for ischemic stroke risk in atrial fibrillation: cohort data covering the entire Korean population
Associate Professor H. Yu (Seoul, KR)
Abstract
Presentation thumbnail
Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry.
Doctor M. Esteve Pastor (Murcia, ES)
Abstract
Presentation thumbnail
Evaluation of appropriate use and clinical outcomes of idarucizumab as antidote of dabigatran in daily clinical practice
Mr S. van der Wall (Haarlem, NL)
Abstract Slides
Presentation thumbnail
The new warfarin dosing algorithm for patients with atrial fibrillation and severe chronic kidney disease
Doctor Z. Salpagarova (Moscow, RU)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Atrial fibrillation - Stroke prevention

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources